Dual Targeting of m7G tRNA Modification and Histone Acetylation using Carrier-Free Nano-Epidrugs to Evoke Osteosarcoma Chemosensitization
{{output}}
Osteosarcoma has witnessed stagnant clinical outcomes over the past four decades, owing to the inevitable reduction in chemosensitivity during treatment. Although epigenetics offers promising strategies to augment chemosensitivity, its role in osteosarcoma rem... ...
